RedHill Biopharma Future Growth

How is RedHill Biopharma forecast to perform in the next 1 to 3 years based on estimates from 1 analyst?

Future Growth Score

0/6

Future Growth Score 0/6

50.8%

Forecasted annual earnings growth

Earnings and Revenue Growth Forecasts

NasdaqGM:RDHL - Analysts future estimates and past financials data (USD Millions)
Date	Revenue	Earnings	Free Cash Flow	Cash from Op	Avg. No. Analysts
12/31/2025	38	-6	-9	-2	1
12/31/2024	21	-23	-24	-17	1
12/31/2023	9	-44	-27	-15	1
9/30/2022	71	-92	-42	-42	N/A
6/30/2022	75	-78	-55	-55	N/A
3/31/2022	78	-95	-57	-57	N/A
12/31/2021	86	-98	-65	-65	N/A
9/30/2021	85	-98	-63	-63	N/A
6/30/2021	84	-95	-54	-54	N/A
3/31/2021	84	-82	-103	-50	N/A
12/31/2020	64	-76	-102	-49	N/A
9/30/2020	44	-64	-104	-50	N/A
6/30/2020	25	-55	-102	-48	N/A
3/31/2020	6	-50	-45	-44	N/A
12/31/2019	6	-42	-41	-41	N/A
9/30/2019	6	-38	-35	-35	N/A
6/30/2019	7	-39	-35	-35	N/A
3/31/2019	8	-39	-33	-32	N/A
12/31/2018	8	-39	-35	-34	N/A
9/30/2018	9	-42	-40	-40	N/A
6/30/2018	8	-47	-44	-43	N/A
3/31/2018	6	-47	-45	-44	N/A
12/31/2017	4	-46	-46	-45	N/A
9/30/2017	2	-43	-42	-41	N/A
6/30/2017	1	-37	-38	-38	N/A
3/31/2017	0	-32	-34	-34	N/A
12/31/2016	0	-29	-28	-28	N/A
9/30/2016	0	-28	-24	-24	N/A
6/30/2016	0	-22	N/A	-20	N/A
3/31/2016	0	-22	N/A	-19	N/A

Earnings vs Savings Rate: RDHL is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: RDHL is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: RDHL is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: RDHL's revenue is expected to decline over the next 3 years (-0.8% per year).

High Growth Revenue: RDHL's revenue is forecast to decline over the next 3 years (-0.8% per year).

Future ROE: Insufficient data to determine if RDHL's Return on Equity is forecast to be high in 3 years time